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INTRODUCTION
Hemorrhagic  Disease  of  Newborn(HDN)  also  called  Vitamin  K  Deficiency 
Bleeding  (VKDB)  is  a  major  cause  of  hemorrhage  in  newborn  and  young  infants. 
Haemorrhagic  disease  of  the  newborn,  first  identified  over  a  hundred years  ago  by 
Townsend1,  presents  as  unexpected  bleeding  in  neonates,  often  with  gastrointestinal 
hemorrhage,  ecchymosis  and,  in  many  cases,  intracranial  hemorrhage  as  a  result  of 
deficiency  of  
vitamin K.
Vitamin K:
Vitamin K is a fat soluble vitamin that can be absorbed from the GI tract in the 
presence of bile salts. Vitamin K is required for the production of coagulation factors II, 
VII, IX and X in the liver. Because of the short half life of these factors, and the small 
amounts of vitamin K that can be stored in the body, inadequate intake of vitamin K can 
result in deficiency in a short period of time. Potein induced in vitamin K absence or 
antagonism(PIVKA), inactive precursor proteins induced in vitamin K's  absence,  are 
measurable and can be used as an indicator of vitamin K deficiency.
Pathophysiology: 
Newborns are relatively vitamin K deficient for a variety of reasons. Factors that 
can contribute to this deficiency include. 
• Low vitamin K stores at birth
• Poor placental transfer of vitamin K, 
• Low  levels  of  vitamin  K  in  breast  milk  (15µg/dL  compared  to  cow’s  milk 
60µg/dl) and 
• Sterility of gut.
Because standard commercial  infant  formulas contain supplemental  vitamin K, 
HDN is almost exclusively a problem of breastfed infants. The most common site of 
bleeding  are  the  umbilicus,  mucous  membranes,  GI  tract,  circumcision,  and 
venipunctures. Intracranial bleeding can occur and is the main cause of mortality and 
long term morbidity.
Types of vitamin K deficiency:
VKDB can occur in 3 general time frames.
• Early onset, at less than 24 hours after birth, rarely occurs and is almost always 
associated  with  maternal  mediations  that  interfere  with  vitamin  K,  such  as 
anticonvulsants, anticoagulants and antibiotics.
• Classic onset of VKDB  occurs 2 -7 days after birth in breast fed infants
• Late onset VKDB occurs after 2 weeks of life. In addition to breastfeeding, risk 
factors include diarrhea, hepatitis, cystic fibrosis(CF), celiac disease, and alpha 1 
antitrypsin deficiency or absence of prophylaxis in otherwise healthy infants
In 1961, the American Academy of Pediatrics recommended that 0.5 to 1 mg of 
vitamin K be administered intramuscularly to all newborns shortly after birth to prevent  
this problem2. This recommendation occurred before the issue of a potential relationship 
between intramuscular vitamin K and childhood cancer was raised and subsequently 
shown to be invalid. In 1988, the Canadian Pediatric Society (CPS) indicated that the 
oral administration of 2 mg of vitamin K within six hours of birth was an acceptable 
alternative3. Several other countries similarly recommended the alternative oral route.   
Subsequently, late HDNB occurring between three to eight weeks of age almost 
exclusively among breast-fed infants,  began to emerge as a serious concern in many 
western  countries.  At  four  to  six  weeks  of  age,  biochemical  signs  of  vitamin  K 
deficiency were evident  in  19% of  infants  given 2 mg of  vitamin K orally  at  birth 
compared to 5.5% of infants given a 1 mg dose intramuscularly. 
In 1997, the CPS4 revised recommendations to go for a single intramuscular dose 
of 0.5 mg (birthweight 1500 g or less) or 1 mg (birthweight greater than 1500 g) should 
be given to all newborns within the first six hours of life.While articles recommending 
continued use of oral vitamin K following birth continued to be published, the ideal 
dose, timing and formulation are not clear for oral prophylaxis and varied throughout.
Late onset VKDB(Late HDN) tends to be more severe than early onset or classic 
disease and has a high frequency of intracranial hemorrhage. Although it is said that 
incidence of HDN has decreased by prophylactic administration of vitamin K, young 
infants with late HDN resulting from vitamin K deficiency still exist. Late HDN occurs 
predominantly  in  exclusively  breastfed  infants,  but  may  also  occur  in  babies  with 
malabsorption,  lack  of  vitamin  K  administration  at  birth,  chronic  diarrhea,  and 
prolonged use of antibiotics. Late HDN produces the greatest morbidity and mortality 
amongst the infants due to sudden bleeding into the CNS.
Incidence of Late HDN in the eastern world is 25-80/1 00 000 births which is 
higher than that in the western world (4-25/100000)5. Almost 2/3rd of the babies with late 
HDN present with serious intracranial bleeds leading to high morbidity and subsequent 
mortality.
Clinical features: 
The findings from the physical examination are normal except for findings at the 
sites of bleeding.
Lab studies:
Include  prothrombin  time  (PT),  activated  partial  thromboplastin  time  (aPTT), 
fibrinogen levels, and a platelet count in the initial workup for bleeding in a newborn. A 
thrombin clotting time is optional.
• A prolonged PT usually is the first laboratory test result to be abnormal in VKDB; 
however, no laboratory test can confirm the diagnosis of VKDB.
• Vitamin K direct assay is not useful because levels normally are low in newborns.
• Levels of protein induced by vitamin K antagonism (PIVKA) II are increased in 
VKDB, but this test generally is not available other than research laboratories.
• Infants with VKDB typically have a prolonged PT with reference range platelet 
counts and fibrinogen levels. 
The diagnosis of VKDB is confirmed if administration of vitamin K brings a halt 
to the bleeding and reduces the PT value.
Imaging Studies: 
Intracranial bleeding is rare and usually associated with other causes of bleeding, 
particularly the thrombocytopenias; however, ICH has been reported in VKDB and can 
be fatal5. Investigate any neurologic symptoms with a CT scan.
Medical Care: 
Prevention of VKDB with intramuscular vitamin K is of primary importance in 
medical care. A single dose of intramuscular vitamin K after birth effectively prevents 
classic VKDB. While oral vitamin K prophylaxis improves coagulation tests at 1-7 days, 
it has not been tested in randomized trials for its effect on either classic or late VKDB. 
• Immediately administer vitamin K subcutaneously for any infant in whom VKDB 
is suspected or who has any sort of bleeding until a diagnosis is established.
• Intramuscular  administration  can  result  in  a  hematoma  because  of  the 
coagulopathy.
• Intravenous  administration  of  vitamin  K  has  been  associated  with 
anaphylactoid reactions.
• Fresh frozen plasma may be considered for moderate-to-severe bleeding.
• Life-threatening bleeding may also be treated with prothrombin complex 
concentrates (PCC). 
• Because the bleeding in classic  VKDB usually is not  life  threatening,  a 
single dose of parenteral vitamin K is sufficient to stop the bleeding and 
return PT values to the reference range.
Prevention:
 In the early 1990s, an association between parenteral vitamin K and the later 
occurrence of childhood cancer was reported; however, a large cohort study and a large 
retrospective  analysis  of  a  database  in  the  United  States  could  not  confirm  this 
association. Because this association is weak at best, routine vitamin K prophylaxis is 
recommended and supported by the American Academy of Pediatrics. 
• Oral vitamin K has been studied as an alternative and can improve clotting studies 
and vitamin K levels, but it has not been studied in large randomized controlled 
trials to determine if an oral prevention strategy is effective at preventing early 
and late VKDB.
REVIEW OF LITERATURE
I] Puneet A. Pooni conducted a study to evaluate the clinical profile and outcome in 
late  hemorrhagic  disease  of  the  newborn  (HDN)  with  particular  reference  to 
intracranial hemorrhage. 
1) Infants (n = 42) presenting with late HDN from January 1998 to December 
2001 were studied. Majority (76%) were in the age group of 1-3 months. 
2) All were term babies on exclusive breast-feeding and none received vitamin 
K at birth. 
3) 71% patients presented with intracranial hemorrhage, commonest site being 
intracerebral and multiple ICH. Visible external bleeding was noted in 1/3rd 
of patients only. Three patients expired
4) Late  HDN  is  still  an  important  cause  of  mortality  and  morbidity  in 
developing  countries  where  vitamin  K  prophylaxis  is  not  routinely 
practiced.  Isolated  intracranial  hemorrhage  is  a  common  mode  of 
presentation.
A neonate fulfilling the following criteria was defined as having late HDN: 
(i)    bleeding in an infant after 7 days of life,
(ii)    no thrombocytopenia (platelet counts >1.5 lac/mm³), 
(iii) normal peripheral blood smear examination,
(iv) prolonged prothrombin time index (PTI) (INR >1.8), and rapid correction of 
PTI or cessation of bleeding after vitamin K administration.
Exclusion criteria: 
Infants with presence of icterus, significant hepatomegaly and / or derangement of 
liver enzymes and failure of PT to return to normal after a single dose of vitamin k were 
considered to have liver disease and excluded.6
Limitations  of  this  study  are  that  the  prevalence  of  late  HDN in  infants  who 
received  vitamin  K  is  not  available  and  whether  vitamin  k  administration  at  birth 
prevents late HDN or not could not be understood. 
II)  Shirahata A et al conducted  a sudy in Japan in 121 instiutes between July 1998 to 
June 2001.
a. 15 cases were definitely diagnosed as vitamin K deficiency according to 
our criterion.
b. The  diagnostic  criterion  of  vitamin  K  deficiency  was  as  follows:  (i) 
Hepaprastin  test  <10%;  (ii)  increase  of  protein  induced  in  vitamin  K 
absence-II (PIVKA-II); and (iii) improvement of abnormal coagulation test 
values after vitamin K administration. The case that filled more than one of 
the mentioned three items was diagnosed as vitamin K deficiency.
c. early onset type and classical  type vitamin K deficiency was the patient 
who had no history of vitamin K administration.
d. Among  late  onset  type  cases,  every  patient  had  received  some  dose  of 
vitamin  K  with  various  methods  before  the  onset  of  the  hemorrhagic 
disease.8
Limitations:
1. only 15 cases over  a follow up of 3 years
2. diagnostic criteria requires more than one items
III) I.E. D’Souza conducted a study in 2003 in clinical profile of  late HDN
• 14 infants diagnosed with late hemorrhagic disease of newborn (LHDN), of which 
10 did not receive vitamin K prophylaxis, are presented.
• All infants were exclusively breast-fed and 12 did not have any underlying illness 
to explain the abnormal coagulation profile.
Any  infant  less  than  6  months’ old  presenting  with  hemorrhage  without  any 
evidence of infection and having a normal platelet count, pro-longed prothrombin time 
(PT) and activated partial thromboblastin time (APTT), which normalized within 12 to 
24 hours after administering vitamin K, was considered to have late HDN.
1. Of 14 infants diagnosed to have late HDN, 8 were boys. Eight were born in 
the hospital of which 4 received intramuscular vitamin K. 
2. All 14 infants were exclusively breast-fed.
3. The age at presentation ranged between 1 and 3 months.
4.  Eight patients, including 5 who were discharged against medical advice, 
died (57%); 6 patients were discharged, of which 5 (36%) had neuro-logical 
sequelae and only one was well
5.  Vitamin  K  prophylaxis  should  be  offered  to  all  newborns  who  are 
exclusively breast-fed.7
STUDY JUSTIFICATION
The  analysis  of  data  collected  for  a  period  of  2  1/2  years  
(Jan 2005 –Jun 2007)  shows that  the total  number  of  cases  of  intracranial  bleeding 
diagnosed in our Institute are 116, of which 61 cases are in the age group of 2 weeks to 6 
months (see table 3 & 4). Hemorrhagic disease of newborn(HDN) diagnosed during this 
period are 75, of which 61 constituted both classical and early HDN and only 14 cases 
belonged to the late onset HDN.
This is an underestimate as many cases could not have been evaluated properly as 
these infants presented with intra cranial bleeding which is a medical emergency and life 
threatening problem. More over young infants with intracranial bleeding may present at 
any time and work up for bleeding diathesis were not available at all times. In such 
situation, cases were managed rather than waiting for diagnosis. Work up for bleeding 
diathesis after the administration of blood products did not contribute to the etiological 
diagnosis.
All the young infants are admitted with intracranial hemorrhage without obvious 
cause,e.g.,  trauma,  liver  disease,  cholestasis,  previous  bleeding  diathesis,  or  family 
history of bleeding diathesis. 
Many  cases  could  not  be  followed  up  as  intra  cranial  bleeding  had a  high 
mortality. Follow up of some of these cases did not reveal any abnormal coagulation 
profile.  This  suggests  that  the  coagulopathy  resulting  in  intracranial  bleeding  is  a 
transient one. Late HDN causes a transient vitamin K deficiency yet life threatening.
Late HDN was considered the possible diagnosis in these young infants. So this 
study was carried out to know the real magnitude of Late HDN in causing intra cranial 
hemorrhage in these infants.
AIM 
To study the pattern of 
a. Intra cranial hemorrhage among infants in the age group of 2 weeks and 
6 months 
b. Late HDN among the cases presenting with intra cranial hemorrhage 
At INSTITUTE OF CHILD HEALTH and HOSPITAL for CHILDREN, Chennai.
SUBJECTS AND METHODS
METHODOLOGY:
DESIGN OF STUDY : Descriptive study
PLACE OF STUDY : PICU, NICU, medical wards and newborn  ward  in 
Institute of Child Health and Hospital for Children, 
Egmore, Chennai-8
PERIOD OF STUDY : Dec 2007 – JUNE 2009
STUDY POPULATION: 
Children evaluated and diagnosed as having intracranial hemorrhage in the age 
group of 2 weeks to 6 months
SAMPLE SELECTION:
INCLUSION CRITERIA:
Children admitted as suspected case of intra cranial hemorrhage in the age group 
of 2 weeks to months
EXCLUSION CRITERIA:
Children  for  whom  intra  cranial  hemorrhage  could  not  be  documented  by 
ULTRASONOGRAM or CT BRAIN were excluded
MANOEUVRE:   
This prospective study evaluates children admitted as intracranial hemorrhage for 
the pattern of presentation, etiology, and proportional morbidity due to Late HDN.
Children admitted in the age group of 2 weeks to 6 months with suspected intra 
cranial  bleeding  (ref:  table  1)  are  included  in  the  study.  Ultra  sound  or  computed 
tomography of cranium was done to confirm the diagnosis of intra cranial bleed. After 
appropriate history and clinical examination, details were entered in the proforma. All 
the  cases  were  worked  up  for  bleeding  diathesis.  For  all  children,  platelet  count, 
peripheral  smear,  prothrombin  time  (PT)  and  activated  partial  thromboplastin  time 
(APTT) were done. Further work up for aetiological diagnosis was done based on the 
above results by following standard protocols (ref: table 4). If both PT and APTT were 
prolonged,  prothrombin  time  is  repeated  after  administering  vitamin  K  (2.5mg  < 
1month, 5 mg >1 month). 
Cases were diagnosed as late onset HDN if following criteria were fulfilled
1. platelet count was normal,   2. Peripheral smear was normal, 3. both PT and APTT 
were prolonged, and 4. PT  normalized after vitamin K administration. 
Clinical profile of cases presenting as late HDN were analyzed.
OUTCOME MEASUREMENT:
Various causes of intra cranial bleed in this age group, causes of  Late HDN, risk 
factors for late HDN, and clinical profile of late HDN
STATISTICAL ANALYSIS:
Proportions of various outcome measures in the form of percentages  as applicable 
and tabulated.
RESULTS
Total number of intra cranial bleeding diagnosed  in this Institute during the study 
period from birth to 12 years -119.
Total  number  of  cases  in  the  age  group  of  2  weeks  to  6  
months – 51(42.8%).
Total number of late onset HDN – 16(31.3%)
S No. Diagnosis Total 
cases
1. Late HDN idiopathic 15
2. Neonatal Cholestasis 8
3. Late HDN – Diarrhoea/antibiotic usage 1
4. Head injury 2
5. Viral hemorrhagic fever/Thrombocytopenia 3
6. Dengue hemorrhagic fever/Thrombocytopenia 1
7 Hemophilia A 1
8 Hypofibringenemia 1
9 Dysfibrinogenemia 1
10 Hemorrhagic meningoencephalitis 1
11 Sepsis/DIC 1
12 Undiagnosed 16
Age of presentation:
Among the cases presented with intracranial bleeding, the common age group of 
presentation were 1 month to 2 months (26 cases – 50.8%).  
Sex:
Male infants  constituted  a  significant  number(62.1%) of  cases presenting  with 
intracranial bleed. 
Symptoms 
The   commonest  symptoms  were  incessant  cry,  refusal  of  feeds,  posturing, 
seizures and vomiting. 
Extra Cranial Bleeding
Intra cranial bleeding was suspected in these infants if they had extra cranial bleed 
in the form of i.m. site hematoma, prolonged i.v. site bleeding, GI or skin bleeds.
One child had late HDN who had preceding illness of diarrhea and had antibiotic 
treatment for the same. 
Clinical features:
Anemia was severe in most of these infant.(mean 7.4 gm%) 
Hemorrhagic shock was present in 20  infants (39.2%)
Features suggestive of ICP(intra cranial pressure) in the form of bulging AF(72.8 
%), unequal pupils(37.3 %), and sluggish pupillary reaction(41.2%).
Side of bleeding 
Left side of bleed was common than the right 
Mortality:
Intracranial bleed had a high mortality(52.9%) of in this case series. 
Among the etiological diagnosis, late HDN was the commonest -16 out of 51 
cases, followed by neonatal cholestasis -8 cases. Among the late HDN, 15 were 
idiopathic and one case had preceding diarrhea and antibiotic usage.
Head injury accounted for 2 cases among the 51 cases. This may be an 
underestimate as cases of road traffic accident and others are directly admitted in 
Neurosurgery Dept, General Hospital before admission in our Institute.
Viral  hemorrhagic  fever  accounted for  3 cases and Dengue hemorrhagic  fever 
accounts for 1 case. Thrombocytopenia was responsible for intracranial bleed. Platelet 
count was less than 15000 in all these cases.
For 2 of  the cases,  the etiological  work up was done on follow up. One was 
diagnosed as hypofibringenemia(prolonged PT and APTT, prolonged Thrombin Time 
and  fibrinogen  level   40mg%).  Another  child  was  diagnosed  as  dysfibrinogenemia 
(prolonged PT, APTT, TT and normal level of fibrinogen).
Interestingly  one  case  was  diagnosed  as  hemorrhagic  meningoencephalitis. 
Fundus examination was hemorrhagic  and lumbar puncture was blood stained in this 
child.MRI was suggestive of  subdural bleed and hemorrhagic meningoencephalitis.
One  child was diagnosed a s Hemophilia A on the basis of prolonged APTT, 
normal PT and factor VIII levels < 1%.
One child had evidence of sepsis and intra cranial bleed was due to DIC. This 
child had prolonged PT,  APTT and low platelet  count.  Klebsiella  was grown in the 
culture.  
In  16  cases,  the  etiological  work  up  could  not  be  done.  Reasons  were  early 
administration of blood products outside, difficult to collect blood in child with severe 
anemia and shock and  high mortality.
Late Hemorrhagic Disease of Newborn:
16 cases were diagnosed as late HDN out of 51 cases(31.3%).
Sex:
Male sex outnumbered female sex in late HDN(75%).
Age Group:
81% of the cases presented between 30 – 60 days.
CLINICAL SYMPTOMS:
Symptoms such as incessant cry, refusal of feed, posturing, seizures and vomiting 
were in the following proportions. 
Extra cranial bleeding:
Exclusive breastfed infants(93.7%) and term(87.5%) were present in high 
proportion in late HDN.
Jaundice  was  seen  in  two  of  these  infants  were  of  unconjugated 
hyperbilirubinemia  and their  liver  function tests  are  normal.  Bilirubin was produced 
form the intra cranial bleed. Except one, all were exclusively breast fed.
Hb % :
Anemia was significant in these young infants as in all cases of intra cranial bleed. 
Most children had Hb % between 3.1 – 6 gm percent.
All  these children had prolonged PT and APTT. Prothrombin time normalized 
with vitamin K. Since fresh frozen plasma was administered in most  of these cases, 
repeat prothrombin time was taken just before the administration of blood products. The 
time  interval  between   the  two  
PT – before and after vitamin K varied from 2 hours to 24 hours. Prothrombin time 
normalized  within 6 hours in some infants, in others it had significantly reduced in 2 
hours almost approaching normal. 
PT BEFORE AND AFTER VITAMIN K 
S. 
No
Initial  PT 
sec
Time bet vit K 
& rpt PT hrs
Post vit K PT 
sec
1. 60 3 12
2. 60 4 11.9
3. 300 4 17.2
4. 300 2 26.2
5. 300 3 15.2
6. 300 2 28.2
7. 40 5 12
8. 300 5 19.2
9. 65.5 5 16.3
10. 300 6 20.6
11. 300 7 18.7
12. 221.9 5 24
13. 60 24 12
14. 300 6 19.2
15. 300 6 13.6
16. 97.8 6 17.6
Clinical Features:
The  pallor,  shock,  bulging  AF,  absent  pupillary  reaction  and  unequal  pupils 
presented in the following proportions . 
As in all intra cranial bleed, parietal bleed was the common site of intra cerebral 
bleed and left sided hemorrhage was common. 

Outcome:
Mortality due to late HDN was 9 out of 16 cases (56.2% ) 
DISCUSSION
During the study period, total of 119 cases presented with intracranial bleeding in 
our INSTITUTE OF CHILD HEALTH, EGMORE from birth to 12 years. 
51 cases(42.8 %) were in the age group of 2 weeks to 6 months(study period).
Late HDN –idiopathic type constituted 13.4 % (16 cases out of 119) of all cases of 
intra cranial bleeding in our institute.
Late HDN – idiopathic type constituted 31.3 %(16 cases out of 51) in the age 
group of 2 weeks to 6 months.
Neonatal cholestasis constituted 8 cases (15.6 %) of intra cranial bleed in the age 
group of 2 weeks to 6 months.
15  cases  (29.4%)  could  not  be  diagnosed  either  due  to  early  death  or   early 
administration of blood products.
The common age group affected by late HDN is 1-2 months. Sex ratio was 4:1(16: 
4 cases).
The common presentations include incessant  cry,  posturing,  vomiting,  seizures 
and refusal of feeds. 
Out of 51 cases of intra cranial bleeding in the study group, 4 cases had umbilical  
bleeding in the neonatal period though they presented with intracranial bleeding later. 
One infant presented at 180 days of life and diagnosed as Hypofibrinogenemia. Other 
infants  presented  at  30  –  45 days  of  life  among which one infant  turned out  to  be 
Dysfibrinogenemia on follow up. Other 4 siblings had late onset HDN.
One  infant who was diagnosed as late HDN,  had a sibling who had intra cranial  
bleed at 2 months of age. They were born of non consanguineous marriage. The cause of 
bleeding in that sibling was not evaluated as the sibling died, could be due to vitamin K 
deficiency itself.
Among 16 cases of late HDN, 14 were term with normal birth weight. 
5 had received vitamin K at birth and 11 cases had not received vitamin K at birth. 
This is similar to the study done by Shirahata et al8 and D’souza et al7 that vitamin K at 
birth may not  offer protection against late onset vitamin K deficiency.
Exclusive  breastfeeding  was  practiced  in  14  out  of  15  cases  of  late  HDN 
idiopathic. This is in concordance with Shirahata et al8 and D’souza et al7 that exclusive 
breast feeding is a risk factor for vitamin K deficiency. 
Clinical findings noted in these children were pallor, shock, bulging AF, unequal 
pupils, sluggish pupillary reaction and posturing.
DPT vaccination  and Late HDN:
One interesting observation is that  4 of the cases of late HDN presented with 
intracranial bleeding one to three days after receiving DPT injection. It is probably due 
to the incessant cry that follows the DPT injection triggers intra cranial bleed. All these 
infants also had i.m. site hematoma suggesting that abnormal coagulation profile was 
present at the time of DPT vaccination.
Vitamin K administration & Prothrombin Time:
Vitamin K significantly corrected the abnormal coagulation profile as early as 2 
hours.  In our study, inj.vitamin K was given after  taking blood sample for  PT  and 
APTT. PT was repeated after 6 hours of administration of vitamin K. However, in 10 
cases PT was done before 6 hours as blood products and fresh frozen plasma had to 
administered.  In  view  of  life  threatening  emergency,  PT  was  repeated  before  the 
administration of blood products as PT may be normalized with these blood products. 
The shortest time interval between the first PT and repeat PT was 2 hours. In 2 of the 
cases, PT was repeated after 2 hours of vitamin K and in both these cases the PT value 
had significantly reduced almost approaching normal.
Graphical representation of PT before and after vitamin K 
Neonatal cholestasis constituted 8 cases out of 51 cases. Neonatal cholestasis was 
diagnosed on the  basis  of  history,  persistent  conjugated hyperbilirubinemia,  elevated 
liver function test and on follow up. In five of these cases, prolonged PT was corrected 
with vitamin K in single dose. 
Other cases were already transfused outside and had normal PT and APTT on admission.
Most intra cranial hemorrhages were on left side and in parietal lobe. Late HDN 
had a mortality of 56 % - 9 died and 7 survived.
SUMMARY
1. Almost 50 % of intracranial bleed  in our INSTITUTE occur <6 months of age 
excluding cases of head injury.
2. In the study population (2 weeks to 6 months),  late onset HDN is the leading 
cause(31.3%) of intra cranial bleed and carries a high mortality
3. Most cases of late HDN occur in the age group of 1-2 months
4. Male  sex,  exclusive  breastfeeding,  diarrhea,  prior  antibiotic  usage  are  all  risk 
factors
5. Late  HDN(31.3%)  and  neonatal  cholestasis(15.6%)  are  the  leading  causes  of 
intracranial hemorrhage in this age group
6. Vitamin K administration at birth may not protect against late onset HDN
7. Vitamin K significantly reduces the prothrombin time as early as 2 hours
8. Other  causes  of  intracranial  bleed  in  this  age  group  in  this  study  are 
hypofibrinogenemia,  dysfibrinogenemia,  hemophilia  A,  hemorrhagic 
meningoencephalitis, and head injury.
CONCLUSION
1. Late  onset  HDN usually presents  as  a  life  threatening problem of intracranial 
bleeding.  It carries a high mortality.
2. Vitamin  K deficiency in idiopathic Late onset HDN is  transient. The deficiency 
manifests mainly in the age group of 1 -2 months. 
3. Vitamin K reverses the prolonged PT  within 2 hours.
4. Hematoma following DPT vaccination is warning sign of intra cranial bleeding
5. If hematoma occurs following any DPT or Hepatitis B vaccination, administration 
of vitamin K may prevent life threatening intra cranial bleeding
6. One must look for jaundice at the time of DPT or Hepatitis B vaccination on 45 th 
day for  early diagnosis  of  neonatal  cholestasis  and avoiding a life  threatening 
intracranial bleeding
7. In view of rarity of this disorder, exclusive breastfeeding must still be continued. 
However unnecessary use of antibiotics which is another risk factor for vitamin K 
deficiency  should be avoided
8. Vitamin  K  may  be  recommended  in  young  infants  on  prolonged  antibiotic 
treatment
Recommendations: 
However recommending routine 2nd dose of vitamin K other than the dose at birth 
needs a cross sectional study to know the abnormal coagulation profile in exclusively 
breast fed normal infants and a multicentric prospective study to know it’s prophylactic 
benefit.
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PROFORMA
CASE NO:                                                                         DOA:
                                                                                           DOD:
                                                                                                 
Name:                                                                                IP no:
Age:                                                                                   ward:                         
Sex:                                                                                    PICU:
Address:                                                                             NICU:
COMPLAINTS:
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joint
                                                                                              
Incessant cry
Irritability
Seizures
Poor sucking
Posturing
ALOC
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e 
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l 
bleed
Fever 
Vomiting
Jaundice 
Breathlessness  
Trauma
PAST HISTORY: 
Hospitalisation:
h/o diarrhea 
h/o malabsorption
h/o antibiotic use 
h/o cystic fibrosis
h/o jaundice 
                              gm%
h/o bleeding tendency
h/o hematoma during injections/DPT inj
FAMILY HISTORY:
h/o bleeding tendency in family members
ANTENATAL HISTORY:
maternal TB  
anti-TB drug intake
maternal epilepsy
anti-epileptic drug intake
anti_coagulant intake
h/o suggestive of  TORCH INFECTION:
medical disease:
pregnancy related disease:
BIRTH HISTORY:
Mode of delivery:
If  LSCS/ forceps, indication:
Admissions:
Vitamin K given/ dose:
EXCLUSIVE BREAST FEEDS:
DEVELOPMENTAL HISTORY: 
IMMUNISATION HISTORY:
EXAMINATION:
GENERAL
Nourishment.  
Sick looking
Febrile 
Wt:
Pallor
Icterus
Bleeding:
ALOC:
Shock:
CVS:
RS:
ABDOMEN: 
Hepatomegaly:
 Liver span:
Splenomegaly:
CNS:
ALOC
Bulging  fontanelle
Absent papillary reaction
Unequal pupils
Posturing
AVPU
DEM
Higher functions:
Cranial nerves:
Tone:
Plantar:
 Other findings:
INVESTIGATIONS 
BLOOD GROUPING:
CBC:
Hb
TC
DC P           L                E
Platelet count                          Lakhs/mm3
Hct                       %
Incessant cry
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S:
ANN
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Table 
1:
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ED 
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EN 
BAB
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1
2 Seizures
3 Posturing
4 Refusal of feeds
5 Vomiting
6 Bleeding manifestations
7 Pallor
8 Bulging anterior fontanel
9 Unequal pupils
10 Sluggish pupillary reaction
11 Abnormal breathing pattern/apnea
Table 2:
Table 3:
Table 4:
ABBREVIATIONS
HDN – Hemorrhagic Disease of Newborn
VKDB – Vitamin K Deficiency Bleeding
PT – Prothrombin Time
APTT – Activated Partial Thromboplalstin Time
TT – Thrombin Time
DIC – Disseminatied Intravascular Coagulation

